And CXCR2+ MDSCs exhibited a high proportion in peripheral blood, bone marrow, spleens and tumor tissues derived from every tumor-bearing mouse on day 35 after breast cancer cells inoculation (Figure 1D). Here, CXCR2 is linked to neoplasm.